Teleflex (Teleflex) Inventories, Finished Goods

: $336 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

Teleflex's quarterly finished goods increased from Jun. 2023 ($322 Mil) to Sep. 2023 ($327 Mil) and increased from Sep. 2023 ($327 Mil) to Dec. 2023 ($336 Mil).

Teleflex's annual finished goods increased from Dec. 2021 ($250 Mil) to Dec. 2022 ($293 Mil) and increased from Dec. 2022 ($293 Mil) to Dec. 2023 ($336 Mil).

Teleflex Inventories, Finished Goods Historical Data

The historical data trend for Teleflex's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

290.78

304.95

249.71

292.87

335.57

Teleflex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventories, Finished Goods																292.87	311.03	322.05	327.49	335.57

Teleflex Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Teleflex (Teleflex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (NYSE:TFX) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

T1FX34:Brazil

Address

550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087

Website

https://www.teleflex.com

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Executives

Liam Kelly	officer: EVP & President, International	IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000
Thomas E Powell	officer: Senior Vice President & CFO	C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717
Stuart A Randle	director	585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Jaewon Ryu	director	950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203
Neena M Patil	director	JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304
Andrew A Krakauer	director	CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Cameron P Hicks	officer: Vice President, Global HR	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Klasko Stephen K. M.d.	director	155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Jay White	officer: VP & Pres, Global Commercial	3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560
Daniel V. Logue	officer: VP, Gen Counsel & Secretary	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
John Deren	officer: VP & Chief Accounting Officer	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
James J Leyden	officer: VP, General Counsel, Secretary	C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014
James Winters	officer: Vice President, Mfg and Supply	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Mario Wijker	officer: Vice President, QARA	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Benson Smith	director	C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976